Tag: myelodysplastic syndromes (MDS)

23-CNR-3965756-CQD-Hero-650×450 Dr Molina
August 1, 2023/Research

Measuring Residual Disease in Leukemias: Improving on Current Assays is a Focus

Single-cell next-gen sequencing showing promise to improve sensitivity of MRD testing

22-CNR-3405922-CQD-Hero-650×450 (1)
January 24, 2023/Research

Graft Failure Rates Negligible Between Patients with Haplo-Identical Donors and those with Matched Unrelated Donors Receiving Cyclophosphamide

Study assesses the impact of donor source and post-transplant prophylaxis for patients receiving a hematopoietic cell transplant

breast cancer cells
December 16, 2022/Research

Researchers Identify Risk Factors of Secondary Malignancy in Breast Cancer Survivors

Prior history of autoimmunity and solid organ transplantation significantly increases chance of myelodysplastic syndrome or acute myeloid leukemia

December 14, 2021/Pediatrics

Study Investigates How Severe Congenital Neutropenia Progresses to Cancer

Research aims to find a biomarker for early detection and intervention


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 14, 2020/Blood Cancers

Decision Support Tool Can Predict Patient Response to Treatment with Hypomethylating Agents

A major advance in prognosis for myelodysplastic syndromes that may improve outcomes

June 17, 2020/Research

Combination Therapy Shows Promising Results in Some Higher-Risk Leukemias

Encouraging clinical efficacy with no rise in adverse events

February 3, 2020/Research

New Approach Leads to Transfusion Independence in Low-risk MDS

Luspatercept shows promise for patients with few options

BackPage 1 of 2Next